Methods for the diagnosis and treatment of lung cancer

Details Methods for the diagnosis and treatment of lung cancer Methods for the diagnosis and treatment of lung cancer

2010-11-22

2011-11-29

Rawlings, Stephen (Department: 1643)

Chemistry: analytical and immunological testing

Cancer

C435S006120, C435S007100, C435S007230, C530S350000, C536S023500, C536S024300

Reexamination Certificate

active

08067240

ABSTRACT:
The present invention provides methods for aiding in the diagnoses of the neoplastic condition of a lung cell and methods of screening for a potential therapeutic agent for the reversal of the neoplastic condition.

REFERENCES:
patent: 3817837 (1974-06-01), Rubenstein et al.
patent: 3850752 (1974-11-01), Schuurs et al.
patent: 3939350 (1976-02-01), Kronick et al.
patent: 3996345 (1976-12-01), Ullman et al.
patent: 4275149 (1981-06-01), Litman et al.
patent: 4277437 (1981-07-01), Maggio
patent: 4366241 (1982-12-01), Tom et al.
patent: 4603102 (1986-07-01), Himmelmann et al.
patent: 5405783 (1995-04-01), Pirrung et al.
patent: 5412087 (1995-05-01), McGall et al.
patent: 5445934 (1995-08-01), Fodor et al.
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 5487992 (1996-01-01), Capecchi et al.
patent: 5578444 (1996-11-01), Edwards et al.
patent: 5578832 (1996-11-01), Trulson et al.
patent: 5627059 (1997-05-01), Capecchi et al.
patent: 5631153 (1997-05-01), Capecchi et al.
patent: 5631734 (1997-05-01), Stern et al.
patent: 5695937 (1997-12-01), Kinzler et al.
patent: 5695980 (1997-12-01), Wei et al.
patent: 5734039 (1998-03-01), Calabretta et al.
patent: 5888796 (1999-03-01), Chang
patent: 2004/0166527 (2004-08-01), Beaudry et al.
patent: 2007/0054274 (2007-03-01), Giordano
patent: 2178022 (1996-12-01), None
patent: 0717113 (1996-06-01), None
patent: H2-53486 (1990-02-01), None
patent: WO 94/07538 (1994-04-01), None
patent: WO 95/20681 (1995-08-01), None
patent: WO 97/10365 (1997-03-01), None
patent: WO 99/50278 (1999-10-01), None
Hibi et al. (Cancer Res. Dec. 15, 1998; 58 (24): 5690-4).
Kennedy et al. (FEBS Lett. Jun. 5, 1998; 429 (1): 17-20).
Borges et al. (1997) “An achaete-scute homologue essential for neuroendocrine differentiation in the lung,” Nature 386:852-855.
Chen et al. (1994) “The second intron of the K-ras gene contains regulatory elements associated with mouse lung tumor susceptibility,” Proc. Natl. Acad. Sci. USA 91:1589-1593.
Chiang et al. (1991) “Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms,” J. Bioi. Chern. 266:18162-18171.
Chisaka et al. (1992) “Developmental defects of the ear, cranial nerves and hindbrain resulting from targeted disruption of the mouse homeobox Gene Hox-1.6,” Nature 355:516-520.
Day & Thompson (1987) “Molecular cloning of cDNA coding for human PGP 9.5 protein,” FEBS Letters 210(2):157-160.
Dhillon et al. (1985) “Neural markers in carcinoma of the lung,” Br. J. Cancer 51 :645-652.
Dorin et al. (1992) “Cystic fibrosis in the mouse by targeted insertional mutagenesis,” Nature 359:211-215.
Ermisch et al. (1995) “Protein gene product (PGP) 9.5 in diagnostic (neuro-) oncology. An immunomorphological study,” Clin. Neuropath. 14(3):130-136.
Gaozar et al. (1996) “NCI Series of Cell Lines: A Historical Perspective,” J. Cell Biochem. Suppl. 24:1-11.
Gilbert et al. (1997) “Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma,” Brit. J. Cancer 75(12)1779-1781.
Golay et al. (1991) “Expression of C-myb and B-myb, but not A-myb, correlates with the proliferation in human hematopoietic cells,” Blood 77(1 ):149-158.
Golay et al. (1996) “Expression of A-myb, but not c-myb and B-myb, is Restricted to Lymphoma, slg+ B-Acute Lymphoblastic Leukemia, and a Subset of Chronic Lymphocytic Leukemias,” Blood 87(5):1900-1911.
Golay et al. (1997) “Redundant Functions of B-Myb and c-Myb in Differentiating Myeloid Cells,” Cell Growth & Differentiation 8: 1305-1316.
Gupta et al. (1995) “Regulation of an eukaryotic initiation factor-2 (eIF-2) associated with 67 kDa Glycoprotein (p67) and its requirement in protein synthesis,” Gene Expression 5(2):113-122.
Hibi et al. (1991) “Serial Analysis of Gene Expression in Non-Small cell Lung Cancer,” Cancer Research 58:5690-5694.
Hibi et al. (1999) “Frequent overexpression of PGP9.5 in a non-small cell lung cancer,” Proceedings of the American Association of Cancer Research 40 :610.
Hojo et al. (1998) “Overexpression of p53 protein in interstitial lung disease,” Respiratory Medicine 92:184-190.
Kasai et al. (1992) “Pulmonary Large Cell Carcinoma Expressing Neuroendocrine Markers: the Morphological, Biological, and Neuroendocrine Features of Their Cell Lines and Surgical Cases,” Jpn. J. Cancer Res. 83:1002-1010.
Kroegel et al. (1996) “Expression von Proto-Onkogenen, Tumor-Suppressor-Genen and dominanten Onkogenen bei Malignomen der Lunge,” Atemw.-Lungenkrkh 2:133-142.
Madden et al. (1997)“SAGE transcript profiles for p53-dependent growth regulation,” Oncogene, 15:1079-1085.
Mooi et al. (1988) “Non-small cell lung carcinomas with neuroendocrine features. A light microscopic, immunohistochemical and ultrastructural study of 11 cases,” Histopathology 13:329-337.
Nomura et al. (1988) “Isolation of human cDNA clones of myb-related genes, A-myb and B-myb,” Nucleic Acids Research 16(23):11075-11089.
Phelps et al. (1996) “NCI-Navy medical oncology branch cell line data base,” J. Cell Biochem. Suppl. 24:32-91.
Rosenwald (1996) “Upregulated expression of the genes coding translation initiation factors elF-4E and elF-2α in transformed cells,” Cancer Letters 102:113-123.
Salgia et al. (1998) “Molecular Abnormalities in Lung Cancer,” J. of Clinical Oncology 16(3):1207-1217.
Saiterwhite et al. (1994) “Inhibition of Cell Growth by TGFβ 1 is Associated with Inhibition of B-myb and Cyclin A in both BALB/MK and Mv1Lu Cells,” Cell Growth & Differentiation 5:789-799.
Stein (1999) “Keeping the biotechnology of antisense in context,” Nature Biotech. 17(3):209.
Velculescu et al. (1995) “Serial analysis of gene expression,” Science 270:484-487.
Venter et al. (1996) “A new strategy for genome sequencing,” Nature 381 :364-366.
Wani et al. (1998) “Enhanced expression of the 8oxo-7,8-dihydrodeoxyguanosine triphosphatase gene in human breast tumor cells,” Cancer Letters 125:123-130.
Wilkinson et al. (1989) “The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase,” Science 246:670-673.
Wu & Wu (1987) “Receptor-mediated in vitro gene transformation by a soluble DNA carrier system,” J. Biol. Chem. 262:4429-4432.

Affiliated with

Also associated with

Rating

Methods for the diagnosis and treatment of lung cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for the diagnosis and treatment of lung cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the diagnosis and treatment of lung cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4253625